Hematology-Oncology Therapy integrates an extensive amount of information that is critical to both office-based and hospital-based clinical practice of hematology and oncology.
Section I: Oncology provides detailed information about the administration, emetogenic potential, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved chemotherapeutic regimens or drugs and biological agents. In addition, each chapter, focused on a specific cancer, contains information about epidemiology, pathology, work-up, and staging, as well as survival data.
Section II: Supportive Care, Drug Preparation, Complications, and Screening consists of topics commonly encountered in clinical hematology-oncology practice.
Section III: Selected Hematologic Diseases provides an authoritative guide to therapy for the principal diseases in consultative hematology.
Contents
Section I: Oncology
- Adrenocortical Cancer
- Anal Cancer
- Gallbladder Cancer and Cholangiocarcinoma
- Bladder Cancer
- Brain Cancer
- Breast Cancer
- Carcinoid Tumors
- Carcinoma of Unknown Primary
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Cancer
- Gastric Cancer
- Gestational Trophoblastic Neoplasia
- Head and Neck Cancers
- Hepatocellular Carcinoma
- HIV-Related Malignancies
- Leukemia, Acute Lymphoblastic (Adult)
- Leukemia, Acute Myelogenous
- Leukemia, Chronic Lymphocytic
- Leukemia, Chronic Myelogenous
- Leukemia, Hairy Cell
- Lung Cancer
- Lymphoma, Hodgkin’s
- Lymphoma, Non-Hodgkin’s
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Ovarian Cancer
- Pancreatic Cancer
- Pheochromocytoma
- Prostate Cancer
- Renal Cell Carcinoma
- Sarcomas
- Testicular Cancer
- Thymic Carcinoma
- Thyroid Cancer
- Vaginal Cancer
Section II: Supportive Care, Drug Preparation, Complications, and Screening
- Chemotherapy-Induced Nausea and Vomiting: Prophylaxis and Treatment
- Drug Preparation and Administration
- Chemotherapy Dose Modifications
- Antineoplastic Drugs: Preventing and Managing Extravasation
- Growth Factors
- Clinical Indications for Bisphosphonates in a Hematology-Oncology Setting
- Transfusion Therapy
- Oncologic Emergencies
- Fever and Neutropenia
- Managing and Preventing Catheter-Related Bloodstream Infections
- Venous Catheter-Related Thrombosis
- Complications and Follow-up After Hematopoietic Stem Cell Transplantation
- Radiation Complications
- Cancer Pain: Assessment and Management
- Hospice Care and End-of-Life Issues
- Cancer Screening
- Genetics of Common Inherited Cancer Syndromes
Section III: Selected Hematologic Diseases
- Von Willebrand Disease
- Hemophilia
- The Hypercoagulable State
- Heparin-Induced Thrombocytopenia (HITT) and HITT With Thromboembolic Syndrome
- Autoimmune Hemolytic Anemia
- Sickle Cell Disease: Acute Complications
- Aplastic Anemia
- Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS)
- Idiopathic Thrombocytopenic Purpura
- Polycythemia Vera
- Essential Thrombocythemia
- Myelodysplastic Syndromes
Index